People with Crohn’s disease know the uncomfortable symptoms of the chronic condition all too well: diarrhea, abdominal pain, weight loss and fatigue, among others. But what doctors have not been able to tell the approximately 565,000 people in the U.S. with Crohn’s is why they’ve developed the inflammatory bowel condition in the first place.
Most experts suspect the condition is the result of the body’s immune system attacking healthy cells, mistakenly triggered by bacteria in the digestive tract. Now, a new study has identified a specific fungus and two bacteria they think play a key role in what leads some people to develop the disease.
“Among hundreds of bacterial and fungal species inhabiting the intestines, it is telling that the three we identified were so highly correlated in Crohn’s patients,” the study’s senior author Mahmoud A. Ghannoum, professor and director of the Center for Medical Mycology at Case Western Reserve and University Hospitals Cleveland Medical Center, said in a press release. - Huffington Post
Good thing we know a solution to the problem. Low Dose Naltrexone is the best treatment out there today. It helps modulate your immune system. Wouldn't it be nice to have a normal, balanced immune system that acts as its suppose to do. Well that's exactly what LDN helps do!
RESULTS: Twelve patients received naltrexone 4.5 mg/day. Duration (mean ±SD) of naltrexone treatment was 46 ±75 weeks (maximum 270 weeks). One patient withdrew after 8 weeks owing to insomnia. Positive clinical responses were reported in 6/12 patients. Two clinical responders had colonoscopy before and after naltrexone and each had complete mucosal healing.
CONCLUSIONS: Adjunctive low dose naltrexone is safe and may be effective in ulcerative colitis patients who are failing conventional therapy. A double blind study is required owing to a high placebo rate in ulcerative colitis. - Leonard B. Weinstock, MD, FACG